Related Experiment Video
Updated: Jun 22, 2025

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
The adhesion-GPCR ADGRF5 fuels breast cancer progression by suppressing the MMP8-mediated antitumorigenic effects
Yalan Wu1, Huixia Liu2, Zhe Sun3
1Department of Histology and Embryology, School of Basic Medical Sciences, Xiangya School of Medicine, Central South University, Changsha, 410013, China.
Abstract:
ADGRF5 (GPR116) has been identified as a facilitator of breast cancer cell migration and metastasis, yet the underlying mechanisms remain largely elusive. Our current study reveals that the absence of ADGRF5 in breast cancer cells impairs extracellular matrix (ECM)-associated cell motility and impedes in vivo tumor growth. This correlates with heightened expression of matrix metalloproteinase 8 (MMP8), a well-characterized antitumorigenic MMP, and a shift in the polarization of tumor-associated neutrophils (TANs) towards the antitumor N1 phenotype in the tumor microenvironment (TME). Mechanistically, ADGRF5 inhibits ERK1/2 activity by enhancing RhoA activation, leading to decreased phosphorylation of C/EBPβ at Thr235, hindering its nuclear translocation and subsequent activation. Crucially, two C/EBPβ binding motifs essential for MMP8 transcription are identified within its promoter region. Consequently, ADGRF5 silencing fosters MMP8 expression and CXCL8 secretion, attracting increased infiltration of TANs; simultaneously, MMP8 plays a role in decorin cleavage, which leads to trapped-inactivation of TGF-β in the TME, thereby polarizing TANs towards the antitumor N1 neutrophil phenotype and mitigating TGF-β-enhanced cell motility in breast cancer. Our findings reveal a novel connection between ADGRF5, an adhesion G protein-coupled receptor, and the orchestration of the TME, which dictates malignancy progression. Overall, the data underscore ADGRF5 as a promising therapeutic target for breast cancer intervention.
Insights
Loss of ADGRF5 in breast cancer hinders cell motility and growth by increasing antitumor MMP8. This promotes an anti-cancer immune response in the tumor microenvironment.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Adhesion G protein-coupled receptor F5 (ADGRF5), also known as GPR116, is implicated in breast cancer cell migration and metastasis.
- The precise molecular mechanisms by which ADGRF5 influences breast cancer progression are not fully understood.
Purpose of the Study:
- To elucidate the role of ADGRF5 in breast cancer cell motility, metastasis, and tumor growth.
- To investigate the molecular pathways linking ADGRF5 to the tumor microenvironment (TME) and immune cell polarization.
Main Methods:
- Investigated the impact of ADGRF5 absence on breast cancer cell migration and in vivo tumor growth.
- Analyzed the expression of matrix metalloproteinase 8 (MMP8) and tumor-associated neutrophils (TANs) in the TME.
- Utilized molecular assays to explore the ADGRF5-ERK1/2-RhoA-C/EBPβ signaling axis.
- Identified C/EBPβ binding motifs in the MMP8 promoter region.
Main Results:
- ADGRF5 absence impaired extracellular matrix (ECM)-associated cell motility and reduced in vivo tumor growth.
- Heightened MMP8 expression and a shift towards antitumor N1 TAN polarization were observed in ADGRF5-deficient tumors.
- ADGRF5 inhibited ERK1/2 activity via RhoA activation, suppressing C/EBPβ phosphorylation and nuclear translocation.
- Silencing ADGRF5 increased MMP8 expression and CXCL8 secretion, enhancing TAN infiltration and promoting N1 polarization.
Conclusions:
- ADGRF5 negatively regulates MMP8 expression and C/EBPβ activation, thereby controlling breast cancer cell motility and TME composition.
- MMP8 contributes to TGF-β inactivation and N1 TAN polarization, opposing TGF-β-driven pro-metastatic effects.
- ADGRF5 represents a novel therapeutic target for modulating the TME and inhibiting breast cancer progression.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Mitogens and the Cell Cycle
Intracellular Signaling Affects Focal Adhesions
Some...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...

